These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity. Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161 [TBL] [Abstract][Full Text] [Related]
9. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome. Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985 [TBL] [Abstract][Full Text] [Related]
10. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome. Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293 [TBL] [Abstract][Full Text] [Related]
11. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. Barone F; Bombardieri M; Rosado MM; Morgan PR; Challacombe SJ; De Vita S; Carsetti R; Spencer J; Valesini G; Pitzalis C J Immunol; 2008 Apr; 180(7):5130-40. PubMed ID: 18354239 [TBL] [Abstract][Full Text] [Related]
13. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment. Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M Front Immunol; 2021; 12():706737. PubMed ID: 34594326 [TBL] [Abstract][Full Text] [Related]
14. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study. De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548 [TBL] [Abstract][Full Text] [Related]
15. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome. Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038 [TBL] [Abstract][Full Text] [Related]
16. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome. Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003 [TBL] [Abstract][Full Text] [Related]